Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC)

De Bono J. S. , Oudard S., Ozguroglu M., Hansen S., Machiels J. H. , Shen L., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, 2010 (SCI İndekslerine Giren Dergi) identifier